Lithobid
Home About Lithobid About Bipolar Disorder Prescribing Information Resources Contact Us


 

Important Notice:

The Lithobid® (lithium carbonate, USP) Patient Assistant Program ended December 31, 2009.

Please ask your HCP what the best course of therapy is for you

We are sorry for any inconvenience this may cause.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.